CDR-restricted engineering of native human scFvs creates highly stable and soluble bifunctional antibodies for subcutaneous delivery-Reference-Cited by-同舟云学术

CDR-restricted engineering of native human scFvs creates highly stable and soluble bifunctional antibodies for subcutaneous delivery

Published:2013-11 Issue:6 Volume:5 Page:882-895
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Fennell Brian J,McDonnell Barry,Tam Amy Sze Pui,Chang Lijun,Steven John,Broadbent Ian D,Gao Huilan,Kieras Elizabeth,Alley Jennifer,Luxenberg Deborah,Edmonds Jason,Fitz Lori J,Miao Wenyan,Whitters Matthew J,Medley Quintus G,Guo Yongjing J,Darmanin-Sheehan Alfredo,Autin Bénédicte,Shúilleabháin Deirdre Ní,Cummins Emma,King Amy,Krebs Mark RH,Grace Christopher,Hickling Timothy P,Boisvert Angela,Zhong Xiaotian,McKenna Matthew,Francis Christopher,Olland Stephane,Bloom Laird,Paulsen Janet,Somers Will,Jensen Allan,Lin Laura,Finlay William JJ,Cunningham Orla

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/mabs.26201

Reference30 articles.

1. Therapeutic antibodies for autoimmunity and inflammation

2. Stability engineering of scFvs for the development of bispecific and multivalent antibodies

3. Rapid optimization and prototyping for therapeutic antibody-like molecules

4. Tumor Regression in Cancer Patients by Very Low Doses of a T Cell–Engaging Antibody

5. Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flow cytometric isolation of drug-like conformational antibodies specific for amyloid fibrils;2023-07-04

2. Engineering of conserved residues near antibody heavy chain complementary determining region 3 (HCDR3) improves both affinity and stability;Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics;2023-07

3. Advanced Formulations/Drug Delivery Systems for Subcutaneous Delivery of Protein-Based Biotherapeutics;Journal of Pharmaceutical Sciences;2022-11

4. Patterns of convergent somatic hypermutations in the adaptive immune response of Mus musculus;2022-10-14

5. More than Toxins—Current Prospects in Designing the Next Generation of Antibody Drug Conjugates;Frontiers in Bioscience-Landmark;2022-08-12